Yhenneko Taylor to Prostatic Neoplasms
This is a "connection" page, showing publications Yhenneko Taylor has written about Prostatic Neoplasms.
Connection Strength
0.412
-
Hall IJ, Taylor YJ, Ross LE, Richardson LC, Richards TB, Rim SH. Discussions about prostate cancer screening between U.S. primary care physicians and their patients. J Gen Intern Med. 2011 Oct; 26(10):1098-104.
Score: 0.066
-
Carson AP, Howard DL, Carpenter WR, Taylor YJ, Peacock S, Schenck AP, Godley PA. Trends and racial differences in the use of androgen deprivation therapy for metastatic prostate cancer. J Pain Symptom Manage. 2010 May; 39(5):872-81.
Score: 0.062
-
Carpenter WR, Howard DL, Taylor YJ, Ross LE, Wobker SE, Godley PA. Racial differences in PSA screening interval and stage at diagnosis. Cancer Causes Control. 2010 Jul; 21(7):1071-80.
Score: 0.062
-
Ross LE, Taylor YJ, Richardson LC, Howard DL. Patterns in prostate-specific antigen test use and digital rectal examinations in the Behavioral Risk Factor Surveillance System, 2002-2006. J Natl Med Assoc. 2009 Apr; 101(4):316-24.
Score: 0.058
-
Gooden KM, Howard DL, Carpenter WR, Carson AP, Taylor YJ, Peacock S, Godley PA. The effect of hospital and surgeon volume on racial differences in recurrence-free survival after radical prostatectomy. Med Care. 2008 Nov; 46(11):1170-6.
Score: 0.056
-
Howard DL, Taylor YJ, Ross LE. Differences in lower urinary tract symptoms, treatment and mortality among African-American and white elderly men. J Natl Med Assoc. 2008 Oct; 100(10):1146-52.
Score: 0.056
-
Ross LE, Powe BD, Taylor YJ, Howard DL. Physician-patient discussions with african american men about prostate cancer screening. Am J Mens Health. 2008 Jun; 2(2):156-64.
Score: 0.053